Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Novel approach for asthma treatment via neurotrophin receptor antagonism

July 12, 2005

CBIQ activates mutant form of CFTR present in 75% of cystic fibrosis patients

July 12, 2005

DA-9601 ameliorates asthma in mice

July 12, 2005

Long-term effects of CRX-675 in a dog model of allergic rhinitis

July 11, 2005

New treatments for respiratory disorders emerge from recent R&D

July 11, 2005

MEN-13510: A new selective NK2 receptor antagonist

July 11, 2005

Structural GenomiX and CFFT form cystic fibrosis drug discovery alliance

July 8, 2005

Biotest and Boehringer Ingelheim to investigate BT-061 for asthma

July 7, 2005

Preliminary results of phase I study of CRX-675 for ragweed allergy

July 7, 2005

LAS-34273 demonstrates fast and sustained 24-hour bronchodilator effect

July 6, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.